Pubs, bars and restaurants across the United Kingdom are losing business as the rapid rise of weight-loss drugs changes consumer behaviour, according to a new report. The findings point to a decline in visits and sales at hospitality venues, with appetite-suppressing medications identified as one of the factors reshaping how often people eat and drink out.
The report highlights that sales have fallen amid a boom in weight-loss treatments, which have become increasingly popular in recent years. Around 16 per cent of the businesses surveyed said visits to their venues had dropped because of the drugs, according to the findings. The medications, often known as weight-loss jabs, are designed to reduce appetite and food intake, and their growing use appears to be feeding through into the hospitality sector.
The impact is not confined to any single part of the country. Venues in Scotland have also reported losing business due to weight-loss jabs, with the same pattern of declining sales emerging north of the border. The trend adds a new dimension to the challenges already facing pubs and restaurants, which have been grappling with rising costs and shrinking disposable income among customers.
Hospitality operators have long warned that tighter household budgets are making people more cautious about spending on meals and drinks. The report places weight-loss drugs alongside those existing pressures, suggesting that the sector now faces a combination of economic and health-driven shifts in consumer habits. For pubs and restaurants, the change in behaviour could mean lower footfall and reduced spending per visit, particularly if more customers are eating and drinking less.
The findings come as the hospitality industry continues to call for support to ease the burden of costs and taxation. Political figures have entered the debate, with attention focused on measures such as VAT and the role of regional leaders in championing the sector. Andy Burnham, the Mayor of Greater Manchester, has been among those associated with efforts to back pubs and hospitality venues, reflecting wider concern about their viability.
The report does not suggest that weight-loss drugs are the sole cause of the downturn. Instead, it identifies them as one of several factors, alongside rising costs and decreasing disposable income, that are affecting bars, pubs and restaurants. That combination makes it harder for venues to plan and invest, especially at a time when many are already operating on thin margins.
For the food and drink industry, the shift raises questions about how to adapt to a customer base that may be consuming less. Some venues could respond by adjusting menus, portion sizes or pricing, while others may look to non-food offerings to attract visitors. The report’s findings underline that the weight-loss drug boom is not only a health story but also an economic one, with consequences for businesses that depend on people’s appetites.
As the use of weight-loss medications continues to grow, the hospitality sector will be watching closely to see whether the decline in visits persists. The report’s snapshot suggests that pubs and restaurants are already feeling the effects, and that the trend is likely to remain part of the industry’s operating landscape for some time.